Search

Search Results

• 

  Duration of treatment for osteoporosis

  Luca Idolazzi, A. Fassio, D. Gatti, S. Tamanini, O. Viapiana, M. Rossini, S. Adami

  22-35

  28-03-2013

  https://doi.org/10.4081/reumatismo.2013.22

  3922

  PDF: 1318
• 

  Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios

  O. Di Munno, A. Delle Sedie

  67-79

  https://doi.org/10.4081/reumatismo.2011.67

  1765

  PDF: 1061

• Anabolic therapy in b-thalassaemia major induced osteoporosis: case report and literature review

  A. Trotta, A. Corrado, F.P. Cantatore

  119-126

  https://doi.org/10.4081/reumatismo.2010.119

  1513

  PDF: 2112

• Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment

  Ombretta Di Munno, Andrea Delle Sedie

  11-21

  https://doi.org/10.4081/reumatismo.2006.11

  1247

  PDF: 1635
• 

  Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life

  G. Adami, A. Giollo, M. Rossini, G. Orsolini, C. Benini, O. Viapiana, D. Gatti, A. Fassio

  71-74

  23-07-2020

  https://doi.org/10.4081/reumatismo.2020.1267

  1916

  PDF: 1293

• The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis

  M. Varenna, D. Gatti

  163-171

  https://doi.org/10.4081/reumatismo.2010.163

  1947

  PDF: 1319